These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25524488)

  • 1. Technology in MicroRNA Profiling: Circulating MicroRNAs as Noninvasive Cancer Biomarkers in Breast Cancer.
    Pimentel F; Bonilla P; Ravishankar YG; Contag A; Gopal N; LaCour S; Lee T; Niemz A
    J Lab Autom; 2015 Oct; 20(5):574-88. PubMed ID: 25524488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
    Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for optimization of microRNA PCR assays for molecular diagnosis.
    Dellett M; Simpson DA
    Expert Rev Mol Diagn; 2016; 16(4):407-14. PubMed ID: 26854938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of serum-circulating miRNA profiling for the identification of breast cancer biomarkers.
    Mar-Aguilar F; Rodríguez-Padilla C; Reséndez-Pérez D
    Methods Mol Biol; 2014; 1165():71-80. PubMed ID: 24839019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of serum genome-wide microRNAs for breast cancer detection.
    Wu Q; Wang C; Lu Z; Guo L; Ge Q
    Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel panel of blood-based microRNAs capable of discrimination between benign breast disease and breast cancer at early stages.
    Sadeghi H; Kamal A; Ahmadi M; Najafi H; Sharifi Zarchi A; Haddad P; Shayestehpour B; Kamkar L; Salamati M; Geranpayeh L; Lashkari M; Totonchi M
    RNA Biol; 2021 Nov; 18(sup2):747-756. PubMed ID: 34793290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
    Hu Z; Dong J; Wang LE; Ma H; Liu J; Zhao Y; Tang J; Chen X; Dai J; Wei Q; Zhang C; Shen H
    Carcinogenesis; 2012 Apr; 33(4):828-34. PubMed ID: 22298638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs for the prediction of metastasis in breast cancer patients diagnosed with early stage disease.
    Inns J; James V
    Breast; 2015 Aug; 24(4):364-9. PubMed ID: 25957467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bias in High-Throughput Analysis of miRNAs and Implications for Biomarker Studies.
    Backes C; Sedaghat-Hamedani F; Frese K; Hart M; Ludwig N; Meder B; Meese E; Keller A
    Anal Chem; 2016 Feb; 88(4):2088-95. PubMed ID: 26760198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
    Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
    Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel panel of microRNAs provides a sensitive and specific tool for the diagnosis of breast cancer.
    Luo J; Zhao Q; Zhang W; Zhang Z; Gao J; Zhang C; Li Y; Tian Y
    Mol Med Rep; 2014 Aug; 10(2):785-91. PubMed ID: 24866395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.
    Asaga S; Kuo C; Nguyen T; Terpenning M; Giuliano AE; Hoon DS
    Clin Chem; 2011 Jan; 57(1):84-91. PubMed ID: 21036945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.
    Kumar S; Keerthana R; Pazhanimuthu A; Perumal P
    Indian J Biochem Biophys; 2013 Jun; 50(3):210-4. PubMed ID: 23898484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct serum assay for microRNA in cancer patients.
    Asaga S; Hoon DS
    Methods Mol Biol; 2013; 1024():147-55. PubMed ID: 23719948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of RNA extraction and sequencing protocols for detection of small RNAs in plasma.
    Wong RKY; MacMahon M; Woodside JV; Simpson DA
    BMC Genomics; 2019 Jun; 20(1):446. PubMed ID: 31159762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Buffy Coat miRNA Profiling for Breast Cancer Prediction in Healthy Women.
    Donzelli S; Blandino G; Muti P
    Methods Mol Biol; 2016; 1379():13-9. PubMed ID: 26608286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.
    Heneghan HM; Miller N; Lowery AJ; Sweeney KJ; Newell J; Kerin MJ
    Ann Surg; 2010 Mar; 251(3):499-505. PubMed ID: 20134314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for candidate microRNA biomarkers in detection of breast cancer: a meta-analysis.
    Lv M; Zhu X; Chen W; Zhao J; Tang J
    Cancer Biomark; 2013; 13(5):395-401. PubMed ID: 24440980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.